Tulane Home Tulane Shield logo linking to site home page

Kidney Clinical Trials

A Phase III Randomized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
More Information

A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the TUHC Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma
More Information

SWOG S1931
Phase III Trial of Immunotherapy-Based Drug Combinations With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE TRIAL)
More Information

PD-inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr (PDIGREE)
More Information

A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Advanced Renal Cell Carcinoma with Bone Metastasis (RadiCaL)
More Information

A Single Arm, Multicenter, Phase 2 Trial to Evaluate the Efficacy of Lenvatinib (LEN) in Combination with Pembrolizumab (KEYtruda) in Subjects with Locally Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
More Information